Advertisement

Journal of Gastroenterology

, Volume 32, Issue 1, pp 134–137 | Cite as

Primary sclerosing cholangitis in Japan—analysis of 192 cases

  • Hajime Takikawa
  • Tadao Manabe
Review

Abstract

Primary sclerosing cholangitis is very rare in Japan. The aim of the present study was to identify the characteristics of such patients in Japan. A questionnaire was sent to the members of the Japanese Society of Gastroenterology and responses for 192 cases were analyzed. There was male predominancy (61%), and two peaks in the age distribution at diagnosis (20–30 years and 50–70 years). Bile duct damage was mainly intra + extrahepatic (69%) versus intrahepatic (17%) or extrahepatic (14%). The incidences of eosinophilia and positivity for anti-nuclear antibody were 27% and 30%, respectively. The incidence of associated inflammatory bowel disease was 21 % (38 ulcerative colitis and 2 Crohn's disease). Chronic pancreatitis, gallstones, and biliary cancers occurred in 15%, 12%, and 4%, respectively, of the 192 patients. Patients less than 40 years of age had a higher incidence than the patients 40 years old or more of damage intra + extrahepatic bile ducts (89% vs 56%) and of associated ulcerative colitis (36% vs 9%), whereas the incidence of chronic pancreatitis was lower in patients aged less than 40 years (4%). The characteristics of patients with primary sclerosing cholangitis in Japan differ from those in other countries in regard to age distribution and the incidence of complications, and at least two different groups of patients seem to exist in terms of the degree of bile duct damage and the incidence of complications.

Key words

primary sclerosing cholangitis inflammatory bowel disease chronic pancreatitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shiraoku H, Hokamura M, Sagara K, et al. A case of primary sclerosing cholangitis. Gastroenterol Jpn 1985;20:368–373.Google Scholar
  2. 2.
    Kashiwabara T, Shibamoto S, Fujimori E, et al. Two cases of primary sclerosing cholangitis-report of two cases and review of the recent literature (in Japanese). Gastroenterol Endosc 1990;32:1194–1204.Google Scholar
  3. 3.
    Yamamoto T, Tomioka T, Tsunoda T et al. A case of primary sclerosing cholangitis (in Japanese). J Bili Tract Pancreas 1993;14:1411–1418.Google Scholar
  4. 4.
    Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989;10:430–436.Google Scholar
  5. 5.
    Rabinovitz M, Gavaler JS, Schade RR, et al. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology 1990;11:7–11.Google Scholar
  6. 6.
    Martin FM, Rossi RL, Nugent EF, et al. Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg 1990;212: 551–556.Google Scholar
  7. 7.
    Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710–1717.Google Scholar
  8. 8.
    Schrumpf E. Abdelnoor M. Fausa O, et al. Risk factors in primary sclerosing chlangitis. J Hepatol 1994;20:1061–1066.Google Scholar
  9. 9.
    Wiesner RH, Porayko MK, LaRusso NF, Ludwig J. Primary sclerosing cholangitis. In: Schiff L, Schiff ER (eds) Diseases of the liver, 7th Ed. Philadelphia: Lippincott, 1993;411–416.Google Scholar
  10. 10.
    Ludwig J, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. Contemp Issues Surg Pathol 1986;8:193–213.Google Scholar
  11. 11.
    Asakura H, Tsuchiya M, Aiso S, et al. Association of human lymphocyte-PR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982;82:413–418.Google Scholar
  12. 12.
    Seki T, Kiyosawa K, Inoko H, et al. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology 1990;12:1300–1304.Google Scholar
  13. 13.
    O'Brien CB, Senior NR, Arora-Mirchandani R, et al. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot study. Hepatology 1991;14:838–847.Google Scholar
  14. 14.
    Stiehl A, Walker S, Stiehl L, et al. Effect of Ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 1994;20:57–64.Google Scholar
  15. 15.
    LaRusso NF, Wiesner RH, Ludwig J, et al. Current concepts: Primary sclerosing cholangitis. N Engl J Med 1984;310:899–903.Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Hajime Takikawa
    • 1
  • Tadao Manabe
    • 2
  1. 1.Department of MedicineTeikyo University School of MedicineTokyoJapan
  2. 2.First Department of Surgery, Faculty of MedicineNagoya City UniversityNagoyaJapan

Personalised recommendations